SIGLEC1 and colorectal carcinoma: Notably, CRC patients exhibiting lower SIGLEC1 expression demonstrated improved survival compared to those with higher SIGLEC1 expression (p < 0.05), as observed in both TCGA and GSE39582 cohorts (Figures 1D and 1E).